Home › NDC Lookup › RxCUI directory › RxCUI 1664988

Aztreonam 2000 MG Injection [Azactam] — RxCUI 1664988

Name: Aztreonam 2000 MG Injection [Azactam] (RxCUI 1664988)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1664988 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1664988

Official nameAztreonam 2000 MG Injection [Azactam]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAzactam 2000 MG Injection; Azactam 2 GM Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)107 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aztreonam Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats serious infections caused by susceptible Gram-negative bacteria. That includes urinary tract, lung, skin, abdominal and gynecologic infections, plus bloodstream infection...
It's given as an injection into a vein or deep into a large muscle. Your prescriber decides the route and how often based on your infection and kidney function. Severe infections u...
The most common are soreness or swelling where you get the shot, vein irritation, diarrhea, nausea, vomiting and rash. These are usually mild. Tell your care team if they bother yo...
Get emergency help for swelling of the face or throat, trouble breathing or hives. Call your doctor for severe or watery diarrhea, even weeks after finishing, or for severe skin pe...

📖 Read our full Aztreonam Injection guide →

🕸️ Concept Web — How Aztreonam 2000 MG Injection [Azactam] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Aztreonam 2000 MG Injection [Azactam] RxCUI 1664988 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Aztreonam 1272 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Azactam 202561 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Aztreonam Injection 1664980 SCDF
- Aztreonam Injectable Product 1155015 SCDG
- Aztreonam Injection [Azactam] 1664983 SBDF
- Azactam Injectable Product 1176315 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Aztreonam 2000 MG Injection 1664986 SCD
- Aztreonam 2000 MG 1664985 SCDC
- Aztreonam 2000 MG [Azactam] 1664987 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Aztreonam 2000 MG Injection SCD · 1664986
Aztreonam 2000 MG SCDC · 1664985
Aztreonam Injection SCDF · 1664980
Aztreonam Injectable Product SCDG · 1155015

Brand-Name Concepts

Aztreonam 2000 MG [Azactam] SBDC · 1664987
Aztreonam Injection [Azactam] SBDF · 1664983
Azactam Injectable Product SBDG · 1176315
Azactam BN · 202561

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1664988 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00003-2560-16	10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2560-16) / 1 INJECTI...	AZACTAM	E.R. Squibb & Sons, L.L.C.	2010-04-01
00003-2570-16	10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2570-16) / 1 INJECTI...	AZACTAM	E.R. Squibb & Sons, L.L.C.	2010-04-01

Observed labelers: E.R. Squibb & Sons, L.L.C. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0457	Injection, aztreonam, 100 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.